| | GUIDELINES FOR SETTING SPECIFIC CONCENTRATION LIMITS FOR |
| | 0,13 | | MB | CARCINOGENS IN ANNEX I OF DIRECTIVE 67/548/EEC - INCLUSION OF |
| | 29 | | stron | POTENCY CONSIDERATIONS |
| | 4397 | | ID | Scientific Committee for Toxicity, Ecotoxicity and the Environment |
| | 2003 | | rok |
| | TABLE OF CONTENTS |
| | 1. EXECUTIVE SUMMARY 3 |
| | 2. INTRODUCTION 3 |
| | 2.1 General description of the EU classification system for carcinogens 3 |
| | 2.2 Need for considering potency in setting specific concentration limits for carcinogens 4 |
| | 2.3 Descriptors of tumorigenic dose 5 |
| | 2.4 Procedure 7 |
| | 2.5 Cases where potency evaluation are difficult or unfeasible 8 |
| | 3. DETERMINATION OF THE CARCINOGENIC POTENCY 8 |
| | 3.1 Determination of the T25 value 8 |
| | 3.2 When to use T25 11 |
| | 3.3 Human data 11 |
| | 3.4 Provisional evaluation of potency classification 11 |
| | 4. ELEMENTS THAT MAY MODIFY THE PRELIMINARY POTENCY EVALUATION 12 |
| | 4.1 Dose-response relationship 12 |
| | 4.2 Site/species/strain/gender activity 12 |
| | 4.3 Mechanisms including genotoxicity 13 |
| | 4.4 Mechanistic relevance to humans 13 |
| | 4.5 Toxicokinetics 14 |
| | 4.6 Other elements relevant to potency evaluation 14 |
| | 4.7 Finalizing potency evaluation 14 |
| | 5. ASSIGNING SPECIFIC CONCENTRATION LIMITS 15 |
| | 5.1 Specific concentration limits for Category 1 carcinogens 15 |
| | 5.2 Specific concentration limits for Category 2 carcinogens 15 |
| | 5.3 Specific concentration limits for Category 3 carcinogens 15 |
| | 6. REFERENCES 16 |
| | ANNEX Illustration of the use of information which affect the potency classification |